Vaccinated COVID-19 Index Cases Are Less Likely to Transmit SARS-CoV-2 to Their Household Contacts: A Cohort Study


Por: Godoy P, Martínez-Baz I, Parron I, García-Cenoz M, Ferras J, Carol M, Bes N, Guillaumes M, Godoy S, Toledo D, Follia N, Miret C, Pardos J, Alsedà M, Plans-Rubio P, Sanz I, Sala MR, Caylà JA, Mendioroz J, Munoz-Almagro C, Castilla J, Domínguez Á and On Behalf Of The Sars-CoV-Transmission To Household Contacts Working Group

Publicada: 1 mar 2024 Ahead of Print: 26 feb 2024
Resumen:
The aim of this study was to evaluate the impact of index case vaccination on SARS-CoV-2 transmission to household contacts. In our epidemiological cohort study (May 2022-November 2023), we surveyed registered index case vaccination status and test results for contacts (testing on day 0, and on day 7 for negative contacts) and calculated the secondary attack rate (SAR), i.e., newly infected contacts/susceptible included contacts. The association of the independent variable, index case COVID-19 vaccination (yes/no), with household contact infection was determined using the adjusted odds ratio (aOR) and its 95% confidence interval (CI). We recorded 181 index cases and 314 contacts, of whom 250 agreed to participate; 16 contacts were excluded upon testing positive on day 0. Of the 234 included contacts, 49.1% were women, and the mean (SD) age was 51.9 (19.8) years. The overall SAR of 37.2% (87/234) was lower in the contacts of both vaccinated index cases (34.9% vs. 63.2%; p = 0.014) and index cases with a previous SARS-CoV-2 infection history (27.0% vs. 46.3%; p = 0.002). Index case vaccination showed a protective effect against infection for their household contacts (aOR = 0.21; 95% CI: 0.07, 0.67). The household SAR was high when the Omicron variant circulated. Vaccinated index cases were less likely to transmit SARS-CoV-2 to their contacts.

Filiaciones:
Godoy P:
 Institut de Recerca Biomédica (IRB Lleida), Universitat de Lleida, 25006 Lleida, Spain

 CIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain

Martínez-Baz I:
 CIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain

 Instituto de Salud Pública de Navarra-IdiSNA, 31008 Pamplona, Spain

Parron I:
 Agència de Salut Publica de Catalunya, 08005 Barcelona, Spain

García-Cenoz M:
 CIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain

 Instituto de Salud Pública de Navarra-IdiSNA, 31008 Pamplona, Spain

Ferras J:
 Agència de Salut Publica de Catalunya, 08005 Barcelona, Spain

Carol M:
 Agència de Salut Publica de Catalunya, 08005 Barcelona, Spain

Bes N:
 Agència de Salut Publica de Catalunya, 08005 Barcelona, Spain

Guillaumes M:
 Agència de Salut Pública de Barcelona, 08023 Barcelona, Spain

Godoy S:
 Institut de Recerca Biomédica (IRB Lleida), Universitat de Lleida, 25006 Lleida, Spain

 Institut Català de la Salut (ICS), 08007 Lleida, Spain

Toledo D:
 CIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain

 Departament de Medicina, Universitat de Barcelona, 08036 Barcelona, Spain

Follia N:
 Agència de Salut Publica de Catalunya, 08005 Barcelona, Spain

Miret C:
 Institut de Recerca Biomédica (IRB Lleida), Universitat de Lleida, 25006 Lleida, Spain

 Agència de Salut Publica de Catalunya, 08005 Barcelona, Spain

Pardos J:
 Agència de Salut Publica de Catalunya, 08005 Barcelona, Spain

Alsedà M:
 Institut de Recerca Biomédica (IRB Lleida), Universitat de Lleida, 25006 Lleida, Spain

 Agència de Salut Publica de Catalunya, 08005 Barcelona, Spain

Plans-Rubio P:
 CIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain

 Agència de Salut Publica de Catalunya, 08005 Barcelona, Spain

Sanz I:
 Agència de Salut Publica de Catalunya, 08005 Barcelona, Spain

Sala MR:
 Agència de Salut Publica de Catalunya, 08005 Barcelona, Spain

Caylà JA:
 Barcelona Tuberculosis Research Unit Foundation, 08008 Barcelona, Spain

Mendioroz J:
 Agència de Salut Publica de Catalunya, 08005 Barcelona, Spain

Munoz-Almagro C:
 CIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain

 Laboratorio de Microbiología, Hospital Sant Joan de Déu, 08950 Barcelona, Spain

Castilla J:
 CIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain

 Instituto de Salud Pública de Navarra-IdiSNA, 31008 Pamplona, Spain

Domínguez Á:
 CIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain

 Departament de Medicina, Universitat de Barcelona, 08036 Barcelona, Spain
ISSN: 2076393X





Vaccines
Editorial
MDPI, MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 12 Número: 3
Páginas:
WOS Id: 001192986400001
ID de PubMed: 38543874
imagen Green Submitted, gold

MÉTRICAS